Thrombin generation testing to monitor warfarin anticoagulation in thrombotic antiphospholipid syndrome patients

被引:0
|
作者
Efthymiou, M. [1 ]
Lawrie, A. S. [1 ]
Mackie, I. J. [1 ]
Machin, S. J. [1 ]
Cohen, H. [2 ]
机构
[1] UCL, London, England
[2] Univ Coll London Hosp NHS Fdn Trust, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:962 / 962
页数:1
相关论文
共 50 条
  • [41] Severe thrombotic events in young patients with antiphospholipid syndrome
    Sundberg, Florencia
    Pedreira, Graciela
    THROMBOSIS RESEARCH, 2012, 130 : S162 - S163
  • [42] Suspension of anticoagulation in patients with primary antiphospholipid syndrome in which a negative antibody antiphospholipid
    Rodriguez-Fernandez, S.
    Saavedra Ramirez, R.
    Espinosa Garriga, G.
    Cervera Segura, R.
    REVISTA CLINICA ESPANOLA, 2009, 209 (07): : 357 - 358
  • [43] Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
    Anunciacion-Llunell, Ariadna
    Munoz, Candido
    Roggenbuck, Dirk
    Frasca, Stefano
    Pardos-Gea, Josep
    Esteve-Valverde, Enrique
    Alijotas-Reig, Jaume
    Miro-Mur, Francesc
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [44] Patients with the Antiphospholipid Syndrome (APLS) Show Hypercoagulability Due to Hypofibrinolysis and Increased Fibrin Generation, but Thrombin Generation Is Variable
    Curnow, Jennifer L.
    Morel-Kopp, Marie-Christine
    Rojas, Ninfa
    Aboud, Margaret
    Ward, Christopher
    BLOOD, 2008, 112 (11) : 1309 - 1310
  • [45] Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin
    Carolina Borges Garcia
    Luciana Parente Costa Seguro
    Luiz Augusto Perandini
    Ana Lúcia de Sá Pinto
    Fernanda Rodrigues Lima
    Carlos Eduardo Negrão
    Eloisa Bonfa
    Eduardo Ferreira Borba
    Rheumatology International, 2014, 34 : 1737 - 1741
  • [46] Acute physical exercise is safe in patients with primary antiphospholipid syndrome with exclusive venous thrombosis and under oral anticoagulation with warfarin
    Garcia, Carolina Borges
    Costa Seguro, Luciana Parente
    Perandini, Luiz Augusto
    de Sa Pinto, Ana Lucia
    Lima, Fernanda Rodrigues
    Negrao, Carlos Eduardo
    Bonfa, Eloisa
    Borba, Eduardo Ferreira
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (12) : 1737 - 1741
  • [47] Thrombin Generation Testing in Patients with Myelofibrosis
    Palova, M.
    Slavik, L.
    Hlusi, A.
    Szotkowski, T.
    Ulehlova, J.
    Divoka, M.
    Navratilova, J.
    Papajik, T.
    CLINICAL LABORATORY, 2018, 64 (09) : 1373 - 1383
  • [48] Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE
    Cohen, H.
    Hunt, B.
    Efythymiou, M.
    Arachchillage, D.
    Ruiz, M.
    Clawson, S.
    Muirhead, N.
    Sylvestre, Y.
    Machin, S.
    Bertolaccini, M. L.
    Dore, C.
    Mackie, I
    Isenberg, D.
    Khamashta, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 84 - 84
  • [49] Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE
    Cohen, H.
    Dore, C. J.
    Clawson, S.
    Hunt, B. J.
    Isenberg, D.
    Khamashta, M.
    Muirhead, N.
    LUPUS, 2015, 24 (10) : 1087 - 1094
  • [50] INVESTIGATIONS OF THROMBIN GENERATION TESTS IN WARFARIN-TAKING PATIENTS
    Papakonstantinou, E.
    Yfantis, E.
    Skourbouti, A.
    Georgoutsou, P.
    Lavda, A.
    Paraskevopoulos, K.
    Paximadakis, E.
    Olympios, C. D.
    Manti, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 671 - 671